Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer

American Journal of Epidemiology

Volumn 160, Issue 4, 2004, Pages 306-316

  Engels, Eric A ^a   Chen, J ^a   Viscidi, R P ^b   Shah, K V ^c   Daniel, R W ^c   Chatterjee, N ^a   Klebanoff, M A ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

BK virus; Brain neoplasms; Child; Leukemia; Neoplasms; Poliovirus; Poliovirus vaccines; Simian virus 40

Indexed keywords

POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

VACCINATION;

ANTIBODY TITER; ARTICLE; BK VIRUS; BRAIN TUMOR; CANCER INCIDENCE; CANCER RISK; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DRUG CONTAMINATION; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; SEROCONVERSION; SIMIAN VIRUS 40; VACCINATION; VIRUS PARTICLE;

ADULT; ANTIBODIES, VIRAL; BK VIRUS; CASE-CONTROL STUDIES; CAUSALITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG CONTAMINATION; FEMALE; FIBROSARCOMA; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; INFANT; MALE; MATERNAL EXPOSURE; NEOPLASMS; NERVOUS SYSTEM NEOPLASMS; POLIOMYELITIS; POLIOVIRUS VACCINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; SEROEPIDEMIOLOGIC STUDIES; SIMIAN VIRUS 40; UNITED STATES; VACCINATION;

EID: 3843145367     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh219     Document Type: Article

References (40)

1. Shah K, Nathanson N. Human exposure to SV40: review and comment. Am J Epidemiol 1976;103:1-12.
2. Institute of Medicine, National Academy of Sciences. Immunization safety review: SV40 contamination of polio vaccine and cancer. Washington, DC: National Academy Press, 2002.
3. Bergsagel DJ, Finegold MJ, Butel JS, et al. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992;326:988-93.
4. Engels EA, Sarkar C, Daniel RW, et al. Absence of simian virus 40 in human brain tumors from northern India. Int J Cancer 2002;101:348-52.
5. Girardi AJ, Sweet BH, Hilleman MR. Factors influencing tumor induction in hamsters by vacuolating virus, SV40. Proc Soc Exp Biol Med 1963;112:662-7.
6. Engels EA, Katki HA, Nielsen NM, et al. Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003;95:532-9.
7. Carroll-Pankhurst C, Engels EA, Strickler HD, et al. Thirty-five year mortality following receipt of SV40-contaminated polio vaccine during the neonatal period. Br J Cancer 2001;85:1295-7.
8. Strickler HD, Rosenberg PS, Devesa SS, et al. Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. JAMA 1998;279:292-5.
9. Heinonen OP, Shapiro S, Monson RR, et al. Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 1973;2:229-35.
10. Rosa FW, Sever JL, Madden DL. Absence of antibody response to simian virus 40 after inoculation with killed-poliovirus vaccine of mothers of offspring with neurologic tumors. (Letter). N Engl J Med 1988;318:1469.
11. Niswander KR, Gordon M, eds. The women and their pregnancies. Philadelphia, PA: W B Saunders Company, 1972.
12. Read JS, Clemens JD, Klebanoff MA. Moderate low birth weight and infectious disease mortality during infancy and childhood. Am J Epidemiol 1994;140:721-33.
13. Klebanoff MA, Read JS, Mills JL, et al. The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med 1993;329:905-8.
14. Shiono PH, Chung CS, Myrianthopoulos NC. Preconception radiation, intrauterine diagnostic radiation, and childhood neoplasia. J Natl Cancer Inst 1980;65:681-6.
15. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989;84:1065-73.
16. Rothman KJ, Greenland S. Case-control studies. In: Rothman KJ, Greenland S, eds. Modern epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1998:93-114.
17. Viscidi RP, Rollison DE, Viscidi E, et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol 2003;10:278-85.
18. Carter JJ, Madeleine MM, Wipf GC, et al. Lack of serological evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003;95:1522-30.
19. de Sanjose S, Shah KV, Domingo-Domenech E, et al. Lack of serological evidence for an association between simian virus 40 and lymphoma. Int J Cancer 2003;104:522-4.
20. Strickler HD, Goedert JJ, Fleming M, et al. Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol Biomarkers Prev 1996;5:473-5.
21. Breslow NE, Chatterjee N. Design and analysis of two-phase studies with binary outcome applied to Wilms tumour prognosis. Appl Stat 1999;48:457-68.
22. Breslow NE, Cain KC. Logistic regression for two-stage case-control data. Biometrika 1988;75:11-20.
23. Chen J. Semiparametric efficient and inefficient estimation for the auxiliary outcome problem with the conditional mean model. (Doctoral dissertation). Seattle, WA: University of Washington, 2002.
24. Ikeda Y, Lister J, Bouton JM, et al. Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal. J Pediatr Surg 1981;16(suppl 1):636-44.
25. Martini F, Iaccheri L, Lazzarin L, et al. SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996;56:4820-5.
26. Martini F, Lazzarin L, Iaccheri L, et al. Different simian virus 40 genomic regions and sequences homologous with SV40 T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002;94:1037-48.
27. Vilchez RA, Madden CR, Kozinetz CA, et al. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-23.
28. Shivapurkar N, Harada K, Reddy J, et al. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359:851-2.
29. Farwell JR, Dohrmann GJ, Marrett LD, et al. Effect of SV40 virus-contaminated polio vaccine on the incidence and type of CNS neoplasms in children: a population-based study. Trans Am Neurol Assoc 1979;104:261-4.
30. Morris JA, Johnson KM, Aulisio CG, et al. Clinical and serologic responses in volunteers given vacuolating virus (SV40) by respiratory route. Proc Soc Exp Biol Med 1961;108:56-9.
31. Shah KV, Willard S, Meyers RE, et al. Experimental infection of rhesus with simian virus 40 (SV40). Proc Soc Exp Biol Med 1969;130:196-203.
32. Minor P, Pipkin PA, Cutler K, et al. Natural infection and transmission of SV40. Virology 2003;314:403-9.
33. Magrath DI, Russell K, Tobin JO. Vacuolating agent. BMJ 1961;2:287-8.
34. Sweet BH, Hilleman MR. The vacuolating virus, SV40. Proc Soc Exp Biol Med 1960;105:420-7.
35. Shah KV, McCrumb FR, Daniel RW, et al. Serological evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst 1972;48:557-61.
36. Meyer HM Jr, Hopps HE, Rogers NG, et al. Studies on simian virus 40. J Immunol 1962;88:796-806.
37. Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses: discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975;102:331-40.
38. Stolt A, Sasnauskas K, Koskela P, et al. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003;84:1499-504.
39. Smith MA, Strickler HD, Granovsky M, et al. Investigation of leukemia cells from children with common acute lymphoblastic leukemia for genomic sequences of the primate polyomaviruses JC virus, BK virus, and simian virus 40. Med Pediatr Oncol 1999;33:441-3.
40. Nielsen NM, Wohlfarht J, Aaby P, et al. Cancer risk in a cohort of polio patients. Int J Cancer 2001;92:605-8.